Certara to Report Third Quarter 2026 Financial Results on November 5th, 2026

What happened

Certara announced it will release its third quarter 2026 financial results before the market opens on Thursday, November 5th, 2026. Company management will hold a conference call at 8:30AM ET to discuss those results, with a live webcast and archived replay available.

Confirmed

Global impact / market context

A scheduled earnings release gives investors a fixed date to review Certara's revenue, costs, and cash available, which means the money on hand. The call lets management explain performance and outlook, helping shareholders judge whether the drug development software business is growing as expected.

Analyst inference

Certara sells biosimulation and regulatory science services, which means software and advice that help drug developers prepare evidence for regulators. Its clients include over 2,600 biopharmaceutical companies, academic institutions, and regulatory agencies. Results can show whether demand for these tools is holding up.

Analyst inference

What to watch

1. The earnings release is scheduled for before market open on November 5th, 2026, and the conference call starts at 8:30AM ET, giving investors a set time to hear management discuss the quarter. Confirmed
2. Listen for any stated change to company guidance, which means management's own forecast for future results, because a raised or lowered outlook would reshape expectations for revenue and costs. Proposed
3. Watch whether management describes drug developers spending more or less on biosimulation and regulatory work, since slower client capital spending could pressure Certara's revenue and profit per sale. Analyst inference

Evidence

• globenewswire.com